Melatonin Glenmark

Melatonin, the active ingredient in Melatonin Glenmark, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia, jet lag and other circadian rhythm sleep disorders in adults.

GNH USA supplies Melatonin Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for global markets while ensuring product quality through stringent quality‑assurance processes and adherence to EU standards.

Melatonin Glenmark acts on melatonin receptors to address sleep‑related conditions.

- Insomnia: helps reduce time to fall asleep and improve sleep continuity. - Jet lag: assists in adjusting the internal clock after rapid time‑zone travel. - Circadian rhythm sleep disorders: supports synchronization of the sleep‑wake cycle in shift‑work or non‑24‑hour rhythm disorders.

Oral melatonin may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Daytime drowsiness - Headache - Dizziness - Nausea

Serious or Rare Side Effects: - Allergic skin reactions (rash, itching) - Mood alterations (depression, irritability) - Severe hypersensitivity (anaphylaxis)

Melatonin should be used with caution in specific populations and clinical situations.

- Pregnancy: safety not established; use only if potential benefit outweighs risk. - Breastfeeding: unknown safety; consider discontinuation. - Underlying medical conditions: caution in patients with depression, epilepsy or autoimmune disorders. - Concomitant use with sedatives: may enhance central nervous system depression. - Drug interactions: review other medications that affect melatonin metabolism. - Store at ambient temperature: keep in original container, protect from moisture and light.

Melatonin can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce melatonin clearance. - CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): can raise melatonin levels. - CYP1A2 inducers (e.g., rifampicin, carbamazepine): may lower melatonin efficacy. - Oral contraceptives: may increase melatonin concentrations.